Literature DB >> 2318457

Rapidly progressing cervical cancer in a patient with human immunodeficiency virus infection.

M A Rellihan1, D P Dooley, T W Burke, M E Berkland, R N Longfield.   

Abstract

Many malignancies occur in association with the acquired immunodeficiency syndrome (AIDS). The incidence of cervical intraepithelial neoplasia is increased in patients with human immunodeficiency virus (HIV) infection, although coexistent HIV infection and cervical cancer have not been described. We describe a patient with HIV infection and a stage IIB, poorly differentiated cervical carcinoma who initially responded well to standard radiation therapy. Relapse at an unusual periclitoral site as well as disseminated carcinomatosis appeared within 2 months. Despite chemotherapy with cisplatin, bleomycin, and mitomycin C, the patient died within 3 months of relapse. This pattern of aggressive tumor behavior may occur more frequently as HIV infection spreads into the heterosexual population. We recommend frequent pelvic and cytologic examinations of HIV-infected women and the consideration of an aggressive treatment approach should invasive carcinoma be detected.

Entities:  

Mesh:

Year:  1990        PMID: 2318457     DOI: 10.1016/0090-8258(90)90159-i

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  12 in total

1.  Induction of human papillomavirus type 16-specific immunologic responses in a normal and an human papillomavirus-infected populations.

Authors:  Wen-Fang Cheng; Chien-Nan Lee; Yi-Ning Su; Ming-Cheng Chang; Wen-Chun Hsiao; Chi-An Chen; Chang-Yao Hsieh
Journal:  Immunology       Date:  2005-05       Impact factor: 7.397

Review 2.  Cost-effective policies for cervical cancer screening. An international review.

Authors:  M C Fahs; S B Plichta; J S Mandelblatt
Journal:  Pharmacoeconomics       Date:  1996-03       Impact factor: 4.981

3.  Induction of human papillomavirus-specific CD4(+) and CD8(+) lymphocytes by E7-pulsed autologous dendritic cells in patients with human papillomavirus type 16- and 18-positive cervical cancer.

Authors:  A D Santin; P L Hermonat; A Ravaggi; M Chiriva-Internati; D Zhan; S Pecorelli; G P Parham; M J Cannon
Journal:  J Virol       Date:  1999-07       Impact factor: 5.103

4.  Detection of human papillomavirus DNA in urine specimens from human immunodeficiency virus-positive women.

Authors:  Joeli A Brinkman; W Elizabeth Jones; Ann M Gaffga; Jonathan A Sanders; Anil K Chaturvedi; Joseph Slavinsky III; John L Clayton; Jeanne Dumestre; Michael E Hagensee
Journal:  J Clin Microbiol       Date:  2002-09       Impact factor: 5.948

Review 5.  Cervicovaginal screening in women with HIV infection: a need for increased vigilance?

Authors:  C A Hankins; J A Lamont; M A Handley
Journal:  CMAJ       Date:  1994-03-01       Impact factor: 8.262

6.  Prevalence of risk factors associated with human papillomavirus infection in women living with HIV. Canadian Women's HIV Study Group.

Authors:  C Hankins; F Coutlée; N Lapointe; P Simard; T Tran; J Samson; L Hum
Journal:  CMAJ       Date:  1999-01-26       Impact factor: 8.262

7.  Increase of human papillomavirus-16 E7-specific T helper type 1 response in peripheral blood of cervical cancer patients after radiotherapy.

Authors:  Félix Giovanni Delgado; Elizabeth Martínez; María Angélica Céspedes; María Mercedes Bravo; María Cristina Navas; Alba Lucía Cómbita Rojas
Journal:  Immunology       Date:  2008-09-05       Impact factor: 7.397

8.  Dysregulated expression of both the costimulatory CD28 and inhibitory CTLA-4 molecules in PB T cells of advanced cervical cancer patients suggests systemic immunosuppression related to disease progression.

Authors:  Agata Kosmaczewska; Dorota Bocko; Lidia Ciszak; Iwona Wlodarska-Polinska; Jan Kornafel; Aleksandra Szteblich; Anna Masternak; Irena Frydecka
Journal:  Pathol Oncol Res       Date:  2011-11-19       Impact factor: 3.201

9.  Analysis of factors contributing to the low survival of cervical cancer patients undergoing radiotherapy in Kenya.

Authors:  Innocent O Maranga; Lynne Hampson; Anthony W Oliver; Anas Gamal; Peter Gichangi; Anselmy Opiyo; Catharine M Holland; Ian N Hampson
Journal:  PLoS One       Date:  2013-10-30       Impact factor: 3.240

10.  Assessing Factors Associated With Survival Among Cervical Cancer Patients in Kenya: A Retrospective Follow-up Study.

Authors:  Damar Osok; Simon Karanja; Yeri Kombe; Eliud Njuguna; Jim Todd
Journal:  East Afr Health Res J       Date:  2018-11-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.